Last reviewed · How we verify

NCT03829085: PADI

Study of the Diet in Patients With the Diagnostic of Acute Pancreatitis

Completed NA Last updated 5 February 2019
What this trial tests

NA trial testing EARLY ORAL REFEEDING in Pancreatitis, Acute in 120 participants. Completed in 31 December 2018.

Timeline
1 June 2017
Primary endpoint
31 December 2018
31 December 2018

Quick facts

Lead sponsorConsorci Sanitari del Garraf
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment120
Start date1 June 2017
Primary completion31 December 2018
Estimated completion31 December 2018
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Consorci Sanitari del Garraf

Who can join

Adults 18 to 95, any sex, with Pancreatitis, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute pancreatitis (AP) is a common condition in emergency services worldwide. Approximately 85% of AP are mild and the patients usually recover within 1 to 2 weeks, not requeiring any critical care and organ support. The management of mild AP conventionally involves fasting, intravenous hydration and adequate analgesia until pain improves in order to prevent stimulation and allow the pancreas gland to rest. The current guidelines recommend the oral food intake should be tried as soon as possible, and beneficial effects or early enteral nutrition with mild AP have been reported in literature. Then, early oral refeeding (EORF) after mild and moderate AP is beneficial, but the optimal timing and starting criteria are unclear. Even now, refeeding after mild and moderate AP is typically started until clinical symptoms have resolved and pancreatic enzymes are decreasing, in a successively increasing manner. The aim of this study is to evaluate length of hospital stay, clinical findings and complications for EORF with immediately full caloric intake in patients with mild and moderate AP.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI trial).
    Ramírez-Maldonado E, López Gordo S, Pueyo EM, Sánchez-García A, et al · · 2021 · cited 37× · PMID 33196485 · DOI 10.1097/sla.0000000000004596
  2. Response to Comment by Dr. Kuang on Our Manuscript "Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI trial)".
    Ramírez-Maldonado E, López Gordo S, Memba R, Jorba R. · · 2024 · PMID 39310339 · DOI 10.1097/as9.0000000000000472

Verify or expand the search:

Other recruiting trials for Pancreatitis, Acute

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03829085.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing